EUVIMEDEUVIMED entdecken
Open Access

Burden and Future Trends of Gastric Cancer in 5 East Asian Countries From 1990 to 2036: Epidemiological Study Analysis Using the Global Burden of Diseases Study 2021

Tianhao Guo iD, Tingting Zhou iD, Wenjie Zhu iD, Yumo Yuan iD, Yifan Hui iD, Wenjian Zhu iD, Weixing Shen iD, Liu Li iD, Wei Wei iD, Haibo Cheng iD, Xiaoyu Wu iD

JMIR Cancer · 03.09.2025 · 11 · e74389-e74389

DOI: 10.2196/74389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JMIR Cancer, online erschienen am 03.09.2025. Verfasst von Tianhao Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine (Jiangsu Province Hospital of Chinese Medicine), 155 H…. Hauptthemen laut MEDLINE: Stomach Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Effective prevention and treatment are urgently needed, since gastric cancer (GC) poses a grave threat to the health and well-being of patients. The 5 East Asian countries (China, Japan, North Korea, South Korea, and Mongolia) represent one of the most significant regions globally in terms of GC burden.

Objective

The goal of this study is to examine the patterns and trends of GC across 5 East Asian countries between 1990 and 2021.

Methods

We retrieved data from the Global Burden of Disease Study (GBD) 2021 regarding the prevalence, incidence, mortality, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life years (DALYs) associated with GC in 5 East Asian countries from 1990 to 2021. We further assessed the burden of GC according to age and sex. We used decomposition analysis to examine the changes in the number of new cases, patients, and deaths related to GC. We also used Joinpoint (Joinpoint Regression Program, Version 5.1.0) and age-period-cohort analysis methods to interpret the epidemiological characteristics of GC. Autoregressive integrated moving average model (ARIMA) and Bayesian age-period-cohort (BAPC) prediction models were used to forecast the GC burden by 2036.

Results

Among the 5 East Asian countries, China recorded the highest incidence, prevalence, death, YLLs, YLDs, and DALYs in both 1990 and 2021. From 1990 to 2021, the age-standardized rates for prevalence, mortality, incidence, YLDs, YLLs, and DALYs across the 5 East Asian countries showed an overall decline, though they remained higher than the global average. In all 5 East Asian countries, individuals aged 65 years and older consistently exhibited the highest rates for prevalence, incidence, mortality, YLDs, YLLs, and DALYs. The prevalence rate in South Korea, the incidence rate in North Korea and Mongolia, and the mortality rate in China are influenced by aging, surpassing the global aging average.

Conclusions

The disease burden of GC in the 5 East Asian countries has consistently ranked high over the past 3 decades, particularly among the older individuals. The burden of GC in the 5 East Asian countries is expected to present a major public health challenge, primarily driven by the large population size and the aging demographic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsHumansMaleGlobal Burden of DiseaseFemaleMiddle AgedAgedDisability-Adjusted Life YearsAsia, EasternPrevalenceIncidenceAdultAged, 80 and overCost of IllnessQuality-Adjusted Life YearsEast Asian People

Stichwörter der Autor:innen

age-period-cohort analysisdisease burdenepidemiological studygastric cancerglobal burden of disease studyjoinpoint regression analysisprediction model

Autor:innen und Institutionen

  • Department of Surgical Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine (Jiangsu Province Hospital of Chinese Medicine), 155 Hanzhong Road, Nanjing, Jiangsu, 210029, China, 86 13805168644.
  • Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
  • Institute of Health and Regimen, Jiangsu Open University, Nanjing, China.
  • Department of Gastroenterology, Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
  • School of Elderly Care Services and Management, Nanjing University of Chinese Medicine, Nanjing, China.
  • Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.

ORCID-Profile: Tianhao Guo, Tingting Zhou, Wenjie Zhu, Yumo Yuan, Yifan Hui, Wenjian Zhu, Weixing Shen, Liu Li, Wei Wei, Haibo Cheng, Xiaoyu Wu

Zitieren

APA

Guo, T., Zhou, T., Zhu, W., Yuan, Y., Hui, Y., Zhu, W., Shen, W., Li, L., Wei, W., Cheng, H., & Wu, X. (2025). Burden and Future Trends of Gastric Cancer in 5 East Asian Countries From 1990 to 2036: Epidemiological Study Analysis Using the Global Burden of Diseases Study 2021. JMIR Cancer, 11, e74389-e74389. https://doi.org/10.2196/74389

Vancouver

Guo T, Zhou T, Zhu W, Yuan Y, Hui Y, Zhu W, et al. Burden and Future Trends of Gastric Cancer in 5 East Asian Countries From 1990 to 2036: Epidemiological Study Analysis Using the Global Burden of Diseases Study 2021. JMIR Cancer. 2025;11:e74389-e74389. doi:10.2196/74389

BibTeX
@article{Guo2025,
  author = {Guo, Tianhao and Zhou, Tingting and Zhu, Wenjie and Yuan, Yumo and Hui, Yifan and Zhu, Wenjian and Shen, Weixing and Li, Liu and Wei, Wei and Cheng, Haibo and Wu, Xiaoyu},
  title = {Burden and Future Trends of Gastric Cancer in 5 East Asian Countries From 1990 to 2036: Epidemiological Study Analysis Using the Global Burden of Diseases Study 2021},
  journal = {JMIR Cancer},
  year = {2025},
  volume = {11},
  pages = {e74389--e74389},
  doi = {10.2196/74389}
}
Kostenlos starten →